The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...
A PDUFA action date of August 8, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for LNZ100 (aceclidine 1.75% ...
Registration has officially opened for the third edition of the Oasys Summit, set to take over the Hyatt Regency in the heart of downtown Indianapolis, May 7-9, 2025. It’s a fitting location for an ...
This common condition, known as presbyopia, affects millions worldwide. However, advancements in contact lens technology offer promising solutions for clearer vision. In recent years, the ...
Computer monovision is not generally recommended for people who like to do a lot of reading. Although monovision does not work for everyone, it is a viable option for people who have presbyopia.
Acuvue sells the largest amount of daily disposable lenses in the world! Their best seller is their monthly disposable, Acuvue Oasys, priced at INR 2,195 for a six lens pack and Acuvue Moist Dailies ...
Mumbai-based ENTOD Pharmaceuticals’ claim to replace reading glasses for presbyopia patients 40 or older with their PresVu eye drop caused a sensation. On Sep 4, DCGI approved the treatment ...
The trial met primary and secondary endpoints, with no serious treatment-related adverse events observed. LNZ100's efficacy and safety were consistent across different demographics, highlighting its ...